AIDS Vaccine Week articles from September 2004

AIDS Vaccine Week archives from September 2004

Candidate HIV type 1 vaccines elicit long-term memory B-cell responses.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Recipients of candidate human immunodeficiency virus type 1 vaccines exhibit long-term memory B-cell responses. "The efficacy and practical application of human immunodeficiency virus type I...

Codon optimization of HIV Tat enhance cell-mediated immune responses.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Codon optimization and ubiquitin conjugation of human immunodeficiency virus-1 Tat lead to enhanced cell-mediated immune responses. "The transactivator protein, Tat, is a potential candidate for...

Glycoprotein microarrays are useful tools in HIV glycobiology.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Oligosaccharide and glycoprotein microarrays are useful tools in HIV glycobiology. According to recent research from the United States, "Defining HIV envelope glycoprotein interactions with host...

Hemagglutinating virus protein induces immune response with HIV vaccine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. "By using the hepatitis B core (HBc) protein gene as a...

Heterologous envelope immunogens contribute to AIDS vaccine protection.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys. According to recent research from the United States, "Because a strategy to elicit broadly neutralizing...

Multi-subtype gp160 DNA immunization induces neutralizing anti-HIV antibodies.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies. "A highly desirable feature for an human immunodeficiency virus type 1 (HIV-1) vaccine is the ability to induce...

Folding and dimerization of HIV-1 protease yields evidence for stable monomer.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The folding and dimerization of HIV-1 protease have yielded evidence for a stable monomer from simulations. "HIV-1 protease (PR) is a major drug target in combating AIDS, as it plays a key role in...

HIV-1 Tat(1-72) protein-coated nanoparticles elicit strong immune responses.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV-1 Tat(1-72) protein-coated nanoparticles generate strong T cell type-1 immune responses. "A significant emphasis has been placed on the development of adjuvants and/or delivery systems to...

Positive data reported for epitope-based HIV-1 vaccine.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) announced the publication of data which showed that an epitope-based HIV-1 vaccine can be designed to induce cytotoxic T lymphocytes (CTL) capable of recognizing viruses from...

South Africa: HIV+ women speak out.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- As part of the Women's Month celebrations in South Africa, a "Day of Hope" was held at Pinetown in KwaZulu-Natal province during August 2004 to tell the stories of three HIV positive women who are...

HIV infections increasing in vulnerable areas of Cambodia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV infections are increasing in vulnerable areas of Cambodia. According to published research from the United States, "In the past decade, Cambodia has been experiencing the most serious HIV/AIDS...

U.S. to withhold $120 million from AIDS fund unless other countries pay up.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- The United States has challenged other countries to pay their share of the world's premier AIDS-fighting fund by the end of September or lose $120 million in U.S. cash. At issue is financing for...

Voluntary HIV testing in GUM clinic increased following education strategy.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Voluntary HIV testing in genitourinary medicine clinics increased following implementation of an education strategy. According to recent research published in the International Journal of STD and...

HIV prevalence increasing in Indonesia.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV prevalence is increasing in Indonesia. According to a study from Indonesia, "Until 1999 the known prevalence of HIV in Indonesia was low, except for isolated geographic groups exposed to Thai...

HIV/hepatitis prevention urgently needed in drug treatment programs in Hungary.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- HIV and hepatitis prevention is urgently needed in drug treatment programs in Hungary. According to published research from the United States, "We assess HIV and hepatitis testing and counseling in...

Low-income AIDS patients to get financial aid for drugs.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Help is on the way for more than 960 low-income North Carolinians with HIV who need money to pay for anti-viral drugs, state health officials said. The legislature recently appropriated $2.75...

Nigeria aims to spend $248 million providing HIV treatment to 200,000 sufferers.
September 6, 2004... 2004 SEP 6 - (NewsRx.com & NewsRx.net) -- Africa's most populous nation plans to spend $248 million on AIDS drugs for 200,000 HIV-infected Nigerians by the end of 2005, according to Health Minister Eyitayo Lambo. Aside from procuring the...

Camelized VH intrabodies against vif neutralize HIV-1 infectivity.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Camelized rabbit-derived VH single-domain intrabodies against vif strongly neutralize HIV-1 infectivity. According to a study from Portugal, "We recently developed a specific single-chain antibody...

Prospects for an AIDS vaccine explored.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Researchers explore the prospects for an AIDS vaccine in a recent issue of Lancet Infectious Diseases. According to a study from the United States, "The unremitting devastation created by the AIDS...

Immunodeficiency model affects class switching to T-independent antigen.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- A new murine model of humoral immunodeficiency specifically affects class switching to T-independent antigens. According to recent research published in the European Journal of Immunology,...

Generex expands HIV vaccine efforts with MGH investigator.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corp. (GNBT) announced that its wholly owned subsidiary, Antigen Express, has established a collaboration with Massachusetts General Hospital to use modified peptide antigens to...

Biopharmaceutical company hosts conference to discuss liposomes.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- NeoPharm, Inc, (Nasdaq:NEOL) announced that it will sponsor a conference, entitled "Advances in Liposomes: New Technologies and New Therapies," in Lincolnshire, Illinois, a suburb of Chicago. ...

Coping behavior associated with health outcomes among HIV-positive youth.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Coping behavior is associated with health outcomes among HIV-positive youth. "This study assessed whether coping styles had an influence on physical health outcomes either concurrently or...

HIV estimate/projection for areas of low level/concentrated epidemics determined.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- A novel approach determines HIV estimates and projections for areas of low level and concentrated epidemics. "This paper describes an approach to making estimates and short term projections of...

HIV prevalence is high in drug users and commercial sex workers in Myanmar.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- HIV prevalence is high in drug users and commercial sex workers in Myanmar. According to recent research published in the journal AIDS Education and Prevention, "Myanmar has a diverse population,...

New guidelines maximize effects of occupational HIV post-exposure prophylaxis.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- New guidelines maximize the effects of occupational HIV post-exposure prophylaxis. "The European Commission funded a project for the standardization of the management of occupational exposures to...

Understanding HIV myths/truths leads to more informed decisions by teenagers.
September 13, 2004... 2004 SEP 13 - (NewsRx.com & NewsRx.net) -- Understanding HIV myths and truths leads to more informed decision by teenagers. According to a study from the United States, "A primary objective for science education is to impart robust...

Fowlpox viruses carrying multiple vaccine antigens constructed.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Scientists have constructed recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory molecules. According to recent research published in the journal Biotechniques,...

HLA-A and -B expression high in subtype C HIV-infected Ethiopians.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- HLA-A and -B allele expression is higher in subtype C HIV-1-infected Ethiopians. According to a study from an international team of researchers, "A cohort of 35 human immunodeficiency virus type 1...

Vaccine partial control of SIV replication causes loss of CD4+ T cells.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Vaccine-based partial control of primary simian immunodeficiency virus replication in macaques resulted in a loss of virus-specific CD4+ T cells with increases in viral loads in the chronic phase. ...

Greater participation of women, adolescents needed in HIV vaccine trials.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Greater participation of women and adolescents is needed in HIV vaccine clinical trials, according to a group of international experts, who attended a consultation on HIV vaccine trials in Lausanne,...

South Africa: Impact of AIDS on women showcased in new movie.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- In a move considered to be a breakthrough in confronting the stigma against HIV/AIDS, a South African film featuring an HIV positive Zulu woman was scheduled to be released in the country during the...

Sociodemographics associated with HIV healthcare access among Hispanic patients.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Sociodemographics are associated with HIV health care access among Hispanic patients. "This study evaluated associations between sociodemographic factors and access to care, use of highly active...

Agency heads trying to find money for AIDS drug programs.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- State officials are trying to "identify federal funds" to help offset prescription costs for HIV/AIDS patients dropped from Mississippi's Medicaid program, a Medicaid official says. Some HIV/AIDS...

GSK grants third voluntary license to South African company.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) has granted a voluntary license under its patents to Feza Pharmaceuticals, a South African joint venture between Creative Outsourcing Solutions International (South Africa) (COSi)...

HIV-positive children in resource-limited setting successfully treated.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Clinicians have been able to reduce mortality rates in HIV-positive children from 15% to 3% in the largest group of children treated with highly active antiretroviral therapy (HAART) in any single...

Recombinant viruses induce protective cellular immunity.
September 20, 2004... 2004 SEP 20 - (NewsRx.com & NewsRx.net) -- Recombinant viruses function as tools to induce protective cellular immunity against infectious diseases. According to recent research published in the journal International Microbiology,...

Promising results announced for AdVac.
September 27, 2004... 2004 SEP 27 - (NewsRx.com & NewsRx.net) -- Dutch biotechnology company Crucell, NV, (CRXL) and Harvard Medical School announced results of a joint study supporting novel vaccine vectors developed by Crucell. The results were outlined in a...

SIVmac Gag p27 capsid protein gene expression in potato reported.
September 27, 2004... 2004 SEP 27 - (NewsRx.com & NewsRx.net) -- Researchers have achieved SIVmac Gag p27 capsid protein gene expression in potatoes. According to published research from the United States, "A cDNA encoding the simian immunodeficiency virus type...

HIV vaccine progresses towards next phase.
September 27, 2004... 2004 SEP 27 - (NewsRx.com & NewsRx.net) -- At the AIDS Vaccine 2004 conference in Lausanne, Switzerland, Merck & Co.'s Executive Director for vaccine research, Dr. Robin Isaacs, announced that one of Merck's candidate HIV vaccines, produced...

SIV vaccine study data presented at AIDS Vaccine 2004.
September 27, 2004... 2004 SEP 27 - (NewsRx.com & NewsRx.net) -- Epimmune, Inc., (EPMN) presented preliminary data from its ongoing SIV (simian immunodeficiency virus) rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland. ...